The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
29
No.
01
January 03, 2003
TCL
Vol.
29
No.
02
January 10, 2003
- Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar
- FDA Forms Office of Combination Products;
- Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;
- Report on Carcinogens Lists Estrogen, UV Light, Wood Dust;
- Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;
- Funding Opportunities
TCL
Vol.
29
No.
03
January 17, 2003
- Panel Urges New Research Consortium For Stomach, Esophageal Cancers
- NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy
- Susan Weiner Named to HHS Panel
- HHS Appoints 13 To Genetics Committee
- Emory Cancer Experiment Launched Into Space
- ASTRO Members Approve Governance, Dues Changes
- Funding Opportunities
TCL
Vol.
29
No.
05
January 31, 2003
- Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians
- Bush To Propose Increase for Cancer Screening, FDA Generics Reviews
- FASEB Urges 10% Increase for NIH in FY04
- NCI Supports New Cervical Cancer Screening Guideline
- Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92
- (8-page issue).
- Includes January Business & Regulatory Report (8-page issue).
CCL
Vol.
26
No.
1
January 31, 2003
- Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer
- Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable
- FDA Approves Gleevec For First Line Rx Of CML
- Fragmin Cuts Risk Of VE By 50 Percent In Study
- Sirolimus-Containing Therapy Reduces GVHD, Study Finds
- Avastin Regimen Bested Chemo Alone In Early Disease
- Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca
- Study Confirms Cancer Risk Increase Due To Combined HRT
- Pill Associated With Cancer In BRCA1 Mutation Carriers
- National Cancer Institute Lists Approved Clinical Trials
